High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Author:
Funder
Institute of Cancer Research
Publisher
BMJ
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1186/s40425-018-0479-7.pdf
Reference26 articles.
1. Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, et al. Pooled analysis of Long-term survival data from phase II and phase III trials of Ipilimumab in Unresectable or metastatic melanoma. J Clin Oncol. 2015;33(17):1889–94.
2. Cai DL, Jin LP. Immune cell population in ovarian tumor microenvironment. J Cancer. 2017;8(15):2915–23.
3. Heong V, Ngoi N, Tan DS. Update on immune checkpoint inhibitors in gynecological cancers. J Gynecol Oncol. 2017;28(2):e20.
4. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–21.
5. Strasner A, Karin M. Immune infiltration and prostate Cancer. Front Oncol. 2015;5:128.
Cited by 384 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer;Current Medicinal Chemistry;2024-12
2. Clinical impact for advanced non-small-cell lung cancer patients tested using comprehensive genomic profiling at a large USA health care system;ESMO Real World Data and Digital Oncology;2024-09
3. Analyzing the Spatial Distribution of Immune Cells in Lung Adenocarcinoma;Journal of Personalized Medicine;2024-08-30
4. Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors;Proceedings of the National Academy of Sciences;2024-08-26
5. Integrating mechanism-based T cell phenotypes into a model of tumor–immune cell interactions;APL Bioengineering;2024-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3